FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063218094> ?p ?o ?g. }

• W2063218094 endingPage "420" @default.
• W2063218094 startingPage "413" @default.
• W2063218094 abstract "Hyperphosphatemia is a paradigmatic finding in late-stage chronic kidney disease (CKD) and consistently associated with adverse outcomes. Preclinical and epidemiological studies strongly support a causative role of hyperphosphatemia for cardiovascular complications, especially with regard to vascular, valvular and soft-tissue calcifications, and for subsequent mortality. Therefore, phosphate management is thought to play a pivotal role in health and longevity of CKD patients. In this regard, phosphate binders are considered the prime option; however, dietary phosphate restriction and intensified dialysis are also valuable supportive tools.Studies on available calcium-free phosphate binders demonstrate potential to interfere with phosphate regulatory factors, such as fibroblast growth factor-23 (FGF23). Magnesium-containing phosphate binding may possess a pleiotropic potential due to its calcification inhibitory properties. Novel phosphate lowering compounds, including colestilan, iron-containing binders and nicotinamide, are underway to extend the armamentarium of phosphate-lowering strategies. An open question remains when to therapeutically counteract phosphate retention by binders. A recent prospective randomized trial in patients with moderate CKD (stages 3b-4) and phosphate levels in the upper normal range demonstrated only moderate reductions in serum phosphate levels, no effects on FGF23, but increased vascular calcification progression with active treatment versus placebo. Another small trial in patients with similar renal function given diets containing approximately 1 g of calcium and 1.4 g of phosphate per day showed neutral calcium and phosphate balances, whereas addition of calcium carbonate as a phosphate binder only caused a positive calcium, but no negative phosphate balance.Adequate phosphate management in end-stage CKD remains a mainstay of our therapeutic approaches in this population, and additional promising drugs are in development and may shortly be available. The timing and indication for phosphate-lowering strategies in predialysis CKD is currently unclear." @default.
• W2063218094 created "2016-06-24" @default.
• W2063218094 creator A5016060089 @default.
• W2063218094 creator A5046643853 @default.
• W2063218094 date "2013-07-01" @default.
• W2063218094 modified "2023-09-27" @default.
• W2063218094 title "Use of phosphate binders in chronic kidney disease" @default.
• W2063218094 cites W1965675690 @default.
• W2063218094 cites W1966419427 @default.
• W2063218094 cites W1978513267 @default.
• W2063218094 cites W1979587730 @default.
• W2063218094 cites W1996387976 @default.
• W2063218094 cites W1996731541 @default.
• W2063218094 cites W1997768246 @default.
• W2063218094 cites W2016919948 @default.
• W2063218094 cites W2023566506 @default.
• W2063218094 cites W2023653442 @default.
• W2063218094 cites W2025817795 @default.
• W2063218094 cites W2033826233 @default.
• W2063218094 cites W2039497118 @default.
• W2063218094 cites W2045847718 @default.
• W2063218094 cites W2053932423 @default.
• W2063218094 cites W2069942555 @default.
• W2063218094 cites W2094710838 @default.
• W2063218094 cites W2098122721 @default.
• W2063218094 cites W2099118267 @default.
• W2063218094 cites W2102734552 @default.
• W2063218094 cites W2105719970 @default.
• W2063218094 cites W2107207648 @default.
• W2063218094 cites W2108116509 @default.
• W2063218094 cites W2108786753 @default.
• W2063218094 cites W2116485051 @default.
• W2063218094 cites W2117116215 @default.
• W2063218094 cites W2117885860 @default.
• W2063218094 cites W2119433093 @default.
• W2063218094 cites W2122136837 @default.
• W2063218094 cites W2124715738 @default.
• W2063218094 cites W2132700529 @default.
• W2063218094 cites W2138829372 @default.
• W2063218094 cites W2142627457 @default.
• W2063218094 cites W2146412642 @default.
• W2063218094 cites W2150640826 @default.
• W2063218094 cites W2152171089 @default.
• W2063218094 cites W2156266150 @default.
• W2063218094 cites W2167011606 @default.
• W2063218094 cites W2328615536 @default.
• W2063218094 doi "https://doi.org/10.1097/mnh.0b013e32836214d4" @default.
• W2063218094 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23736841" @default.
• W2063218094 hasPublicationYear "2013" @default.
• W2063218094 type Work @default.
• W2063218094 sameAs 2063218094 @default.
• W2063218094 citedByCount "27" @default.
• W2063218094 countsByYear W20632180942013 @default.
• W2063218094 countsByYear W20632180942014 @default.
• W2063218094 countsByYear W20632180942015 @default.
• W2063218094 countsByYear W20632180942016 @default.
• W2063218094 countsByYear W20632180942017 @default.
• W2063218094 countsByYear W20632180942018 @default.
• W2063218094 countsByYear W20632180942021 @default.
• W2063218094 countsByYear W20632180942022 @default.
• W2063218094 crossrefType "journal-article" @default.
• W2063218094 hasAuthorship W2063218094A5016060089 @default.
• W2063218094 hasAuthorship W2063218094A5046643853 @default.
• W2063218094 hasConcept C114276007 @default.
• W2063218094 hasConcept C126322002 @default.
• W2063218094 hasConcept C134018914 @default.
• W2063218094 hasConcept C185592680 @default.
• W2063218094 hasConcept C2776036575 @default.
• W2063218094 hasConcept C2777132085 @default.
• W2063218094 hasConcept C2777425297 @default.
• W2063218094 hasConcept C2778653478 @default.
• W2063218094 hasConcept C2779148903 @default.
• W2063218094 hasConcept C2779978075 @default.
• W2063218094 hasConcept C2781208988 @default.
• W2063218094 hasConcept C519063684 @default.
• W2063218094 hasConcept C55493867 @default.
• W2063218094 hasConcept C71924100 @default.
• W2063218094 hasConceptScore W2063218094C114276007 @default.
• W2063218094 hasConceptScore W2063218094C126322002 @default.
• W2063218094 hasConceptScore W2063218094C134018914 @default.
• W2063218094 hasConceptScore W2063218094C185592680 @default.
• W2063218094 hasConceptScore W2063218094C2776036575 @default.
• W2063218094 hasConceptScore W2063218094C2777132085 @default.
• W2063218094 hasConceptScore W2063218094C2777425297 @default.
• W2063218094 hasConceptScore W2063218094C2778653478 @default.
• W2063218094 hasConceptScore W2063218094C2779148903 @default.
• W2063218094 hasConceptScore W2063218094C2779978075 @default.
• W2063218094 hasConceptScore W2063218094C2781208988 @default.
• W2063218094 hasConceptScore W2063218094C519063684 @default.
• W2063218094 hasConceptScore W2063218094C55493867 @default.
• W2063218094 hasConceptScore W2063218094C71924100 @default.
• W2063218094 hasIssue "4" @default.
• W2063218094 hasLocation W20632180941 @default.
• W2063218094 hasLocation W20632180942 @default.
• W2063218094 hasOpenAccess W2063218094 @default.
• W2063218094 hasPrimaryLocation W20632180941 @default.
• W2063218094 hasRelatedWork W1997203483 @default.
• W2063218094 hasRelatedWork W2063218094 @default.

• next